Association of C4d deposition with clinical outcomes in IgA nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 5, 2014, Pages 897-904

  Espinosa, Mario ^a   Ortega, Rosa ^a   Sanchez, Marina ^a   Segarra, Alfons ^a   Salcedo, Maria Teresa ^a   Gonzalez, Fayna ^a   Camacho, Rafael ^a   Valdivia, Miguel Angel ^a   Cabrera, Rocio ^a   Lopez, Katia ^a   Pinedo, Fernando ^a   Gutierrez, Eduardo ^a   Valera, Alfonso ^a   Leon, Miryam ^a   Cobo, Maria Angeles ^a   Rodriguez, Rosa ^a   Ballar Ín, Jose ^a   Arce, Yolanda ^a   Garc Ía, Beatriz ^a   Munoz, Mar Ía Dolores ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C4D; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ADULT; ARTICLE; CELL PROLIFERATION; DIALYSIS; END STAGE RENAL DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; OUTCOME ASSESSMENT; PATHOGENESIS; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; BIOPSY; CHEMISTRY; COMPLICATION; DISEASE COURSE; END STAGE LIVER DISEASE; HYPERTELORISM; KAPLAN MEIER METHOD; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; YOUNG ADULT;

ADULT; BIOPSY; COMPLEMENT C4B; DISEASE PROGRESSION; END STAGE LIVER DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTELORISM; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MESANGIAL CELLS; MIDDLE AGED; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84920286729     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09710913     Document Type: Article

References (36)

1. Wyatt R, Julian B: IgA nephropathy. N Engl J Med 368: 2402–2414, 2013
2. Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M; Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Espan~ola de Nefrología (GLOSEN): Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23: 1753–1760, 2012
3. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347: 738–748, 2002
4. Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z: Long-term renal survival and related risk factors in patients with IgA ne-phropathy: Results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 27: 1479–1485, 2012
5. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility. Kidney Int 76: 546–556, 2009
6. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D’Agati V, D’Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int 76: 534–545, 2009
7. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA: The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22: 1795–1803, 2011
8. Giannakakis K, Feriozzi S, Perez M, Faraggiana T, Muda AO: Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy. J Am Soc Nephrol 18: 3139–3146, 2007
9. van den Dobbelsteen MEA, van der Woude FJ, Schroeijers WEM, van den WallBake AWL, Vanes LA, Daha MR: Bindingofdimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 46: 512–519, 1994
10. Duque N, Gómez-Guerrero C, Egido J: Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 159: 3474–3482, 1997
11. Lai KN, Tang SC, Guh JY, Chuang TD, Lam MF, Chan LY, Tsang AW, Leung JC: Polymeric IgA1 from patients with IgA nephrop-athy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 14: 3127–3137, 2003
12. Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J: Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA ne-phropathy. J Am Soc Nephrol 23: 1579–1587, 2012
13. Bogers WM, Stad RK, van Es LA, Daha MR: Immunoglobulin A: Interaction with complement, phagocytic cells and endothelial cells. Complement Inflamm 8: 347–358, 1991
14. Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR: Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17: 1724–1734, 2006
15. Watschinger B, Pascual M: Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection. J Am Soc Nephrol 13: 2420–2423, 2002
16. Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P: Mesangial C4d deposition: A new prognostic factor in IgA nephropathy. Nephrol Dial Transplant 24: 886–891, 2009
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461–470, 1999
18. D’Amico G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 36: 227–237, 2000
19. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F: Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis 18: 12–19, 1991
20. Koyama A, Igarashi M, Kobayashi M; Research Group on Progressive Renal Diseases: Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 29: 526–532, 1997
21. Haas M: Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis 29: 829– 842, 1997
22. Bartosik LP, Lajoie G, Sugar L, Cattran DC: Predicting progression in IgA nephropathy. Am J Kidney Dis 38: 728–735, 2001
23. Li PK, Ho KK, Szeto CC, Yu L, Lai FM: Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives. Nephrol Dial Transplant 17: 64–69, 2002
24. Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L: Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol 22: 752–761, 2011
25. Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, Zhao MH, Bruijn JA, Bajema IM: Pros and cons for C4d as a biomarker. Kidney Int 81: 628–639, 2012
26. Zwirner J, Felber E, Herzog V, Riethmüller G, Feucht HE: Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int 36: 1069–1077, 1989
27. Zhang W, Lachmann PJ: Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology 81: 137–141, 1994
28. Zhao N, Hou P, Lv J, Moldoveanu Z, Li Y, Kiryluk K, Gharavi AG, Novak J, Zhang H: The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 82: 790–796, 2012
29. Endo M, Ohi H, Satomura A, Hidaka M, Ohsawa I, Fujita T, Kanmatsuse K, Matsushita M, Fujita T: Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy. Clin Nephrol 55: 185–191, 2001
30. Hessing M: The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system. Biochem J 277: 581–592, 1991
31. Chang A, Kowalewska J, Smith KD, Nicosia RF, Alpers CE: A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy. Clin Nephrol 66: 397–404, 2006
32. El Karoui K, Hill GS, Karras A, Jacquot C, Moulonguet L, Kourilsky O, Frémeaux-Bacchi V, Delahousse M, Duong Van Huyen JP, Loupy A, Bruneval P, Nochy D: A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol 23: 137–148, 2012
33. Jiang L, Zhang JJ, Lv JC, Liu G, Zou WZ, Zhao MH, Zhang H: Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions. Nephrol Dial Transplant 23: 3921–3927, 2008
34. Suzuki T, Horita S, Kadoya K, Mitsuiki K, Aita K, Harada A, Nitta K, Nagata M: C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clin Exp Nephrol 11: 287–291, 2007
35. Espinosa-Hernández M, Ortega-Salas R, López-Andreu M, Gómez-Carrasco JM, Pérez-Sáez MJ, Pérez-Seoane C, Aljama-García P: C4d as a diagnostic tool in membranous nephropathy. Nefrologia 32: 295–299, 2012
36. Val-Bernal JF, Garijo MF, Val D, Rodrigo E, Arias M: C4d immu-nohistochemical staining is a sensitive method to confirm im-munoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis. Histol Histopathol26: 1391–1397, 2011